New mRNA shot tested to fight Virus-Linked cancers
NCT ID NCT07349836
Summary
This early-stage study is testing a new type of treatment called mRNA immunotherapy for cancers caused by the Epstein-Barr virus (EBV), like some lymphomas and stomach cancers. It will be given to about 40 adults, either by itself or combined with another immunotherapy drug. The main goal is to see if the treatment is safe, while also checking if it helps shrink tumors or slow the cancer's growth.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EBV-ASSOCIATED TUMORS are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.